CDK1 and malignant glioma: Conversely, silencing KAT8 in malignant glioma cells downregulated cyclin-dependent kinase 1 (CDK1), cyclin A, and cyclin B expression and upregulated p21 expression, leading to G2/M-phase arrest [19].